Holocene Advisors’s National Health Investors NHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.22M Buy
33,808
+26,465
+360% +$1.94M 0.01% 470
2026
Q2
$560K Buy
+7,343
New +$562K ﹤0.01% 730
2023
Q3
– Sell
-11,909
Closed -$624K – 823
2023
Q2
$624K Buy
11,909
+252
+2% +$13K ﹤0.01% 664
2023
Q1
$601K Buy
11,657
+2,164
+23% +$118K ﹤0.01% 632
2022
Q4
$496K Sell
9,493
-17,546
-65% -$962K ﹤0.01% 623
2022
Q3
$1.53M Sell
27,039
-8,191
-23% -$516K 0.01% 505
2022
Q2
$2.14M Hold
35,230
– – 0.01% 512
2022
Q1
$2.08M Hold
35,230
– – 0.01% 500
2021
Q4
$2.02M Buy
+35,230
New +$1.95M 0.01% 533
2018
Q2
– Sell
-4,510
Closed -$303K – 679
2018
Q1
$303K Buy
+4,510
New +$308K 0.01% 396

Other funds holding NHI

Holocene Advisors's NHI Position: Q3 2026 in Review

Holocene Advisors increased its National Health Investors (NHI) stake by 360% in Q3 2026, buying an estimated $1.94M and bringing the position to 33,808 shares worth $2.22M. The position accounts for 0.01% of the portfolio, ranked #470.

Holocene Advisors first reported a position in NHI in Q1 2018 and has held it in 10 quarters since. 325 funds tracked by Wall St. Rank hold NHI as of Q3 2026.

  • Holocene Advisors held 33,808 shares of National Health Investors worth $2.22M as of Q3 2026.
  • Holocene Advisors bought 26,465 National Health Investors shares in Q3 2026, an estimated $1.94M.
  • National Health Investors made up 0.01% of Holocene Advisors's portfolio in Q3 2026, its #470 holding.
  • Holocene Advisors first reported a position in National Health Investors in Q1 2018 and has held it in 10 quarters since.
  • 325 funds tracked by Wall St. Rank held National Health Investors as of Q3 2026.

Based on Holocene Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.